Home > Neurology > MS Relapses “Belong to the Past”: Ofatumumab Safety Good

MS Relapses “Belong to the Past”: Ofatumumab Safety Good

Presented By
Prof. Stephen L. Hauser , University of California, San Francisco (UCSF), USA
Trial
ASCLEPIOS, ALITHIOS
Prof. Stephen L. Hauser is a professor of the Department of Neurology at the University of California, San Francisco (UCSF), USA. His work specializes in immune mechanisms and multiple sclerosis (MS). Hauser trained in internal medicine at the New York Hospital-Cornell Medical Center, in neurology at the Massachusetts General Hospital (MGH), and in immunology at Harvard Medical School and the Institute Pasteur in Paris, France, and was a faculty member at Harvard Medical School before moving to UCSF. He has contributed to the establishment of consortia that have identified more than 50 gene variants that contribute to MS risk. In August 2020, the fully human anti-CD20 monoclonal antibody ofatumumab was approved for the treatment of relaps...


Please login to read the full text of the article.


If you have no account yet, please register now.





Posted on